Alzheimer's Disease & Boluoke
While the popular news may be focused on a viral pandemic, there are many other stealth pandemics running amuck in human health. Alzheimer’s disease (AD) is rising dramatically. More than 6 million people in the United States are affiliated with Alzheimer’s disease. The death rate for this disease is higher than both breast and prostate cancer combined.
Not only does Alzheimer’s disease steal the memory and quality of life from those afflicted, it is also a tremendous financial and emotional burden for family members. 11 million people report giving free care to family members with Alzheimer’s disease at a cost of $355 million in 2021. Since the start of the COVID-19 pandemic, the death rate from Alzheimer’s disease has increased by 16%.
Solutions, treatments, and a cure for Alzheimer’s disease is imperative. Alzheimer’s disease has gotten the nickname of “Type 3 Diabetes” because people with Type 2 Diabetes have a much higher risk of developing Alzheimer’s disease. An adult with Type 2 Diabetes is 10-15 times more likely to develop Alzheimer’s disease. Additionally, the APOE4 gene leaves many people susceptible to high insulin within their brains.
Recent research has shed some light on the causes and symptoms of Alzheimer’s disease. Amyloid plaque is a notable symptom of Alzheimer’s disease. These plaques can be seen on imaging and their cause has not been fully discovered. New findings prove that amyloid plaques can be caused by fibrinogen that has leaked across the blood brain barrier. This research suggests that there are several issues to deal with in Alzheimer’s disease: fibrinogen formation and leaky blood brain barrier.
Fibrinogen is a protein found in your bloodstream. It is essential for coagulation and clotting your blood. Imagine if you cut your finger and didn’t have enough fibrinogen for the bleeding to slow and scab. And on the other hand, imagine if you have too much fibrinogen in your bloodstream, which leads to excessive coagulation and clotting.
A simple enzyme can alter the fibrinogen levels in your bloodstream without side effects. Lumbrokinase enzymes have a long and ancient history in Eastern medicine. For centuries, Traditional Chinese Medicine (TCM) doctors have recorded the recipe for ground earthworm tea being used for cardiovascular problems, clots, and thick blood.
Boluoke is the only patented formulation of lumbrokinase that has been medically verified. This preparation has been used in medical studies since the early 1980s when Dr. Hisashi Miahra and his team successfully isolated the exact enzymes within the earthworm powder. Before their research, scientists and Traditional Chinese Medicine (TCM) doctors didn’t know exactly why earthworm powder helped with circulation and blood clots and fibrinogen.
Boluoke is recommended for blood clots and chronic disease states. In particular, Boluoke is used as a biofilm buster for chronic infections such as Lyme disease.
Lumbrokinase enzymes have been used in mouse experiments. The enzyme was effective at breaking down insulin amyloid plaque in mice with AD. In another experiment, lumbrokinase enzymes were compared to nattokinase supplements. Lumbrokinase proved more effective at dissolving amyloid plaques. These are promising results and hopefully human trials will occur quickly.
The best solution for Alzheimer’s is prevention. A low carbohydrate diet which supports stable blood sugar and normal insulin levels is your first line of defense. This will prevent or at least slow formation of amyloid plaques. Beyond that, lumbrokinase enzymes may help to dissolve amyloid plaques. While we may not know what is causing the fibrinogen which creates the plaques, we do have a natural and easy solution to dissolving them. Scientists have yet to determine what is causing leaky blood brain barriers.
To read more about how to take Boluoke and my personal story of using it, visit my other blog post on this subject.
Links to the research articles
- Lumbrokinase for Degradation and Reduction of Amyloid Fibrils Associated with Amyloidosis
- Fibrinogen Induces Microglia-Mediated Spine Elimination and Cognitive Impairment in an Alzheimer’s Disease Model
- Attenuation of subcutaneous insulin-induced amyloid mass in vivo using Lumbrokinase and Serratiopeptidase
- https://www.researchgate.net/publication/312631888_Lumbrokinase_for_degradation_and_reduction_of_amyloid_fibrils_associated_with_amyloidosis
- https://www.eurekaselect.com/175974/article
- https://www.fightaging.org/archives/2019/02/more-on-fibrinogen-and-blood-brain-barrier-leakage-in-the-aging-brain/
- https://source.wustl.edu/2006/11/naturally-occurring-enzyme-can-break-down-alzheimer-plaques/
